BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bennett A, Tacca MD, Stamford IF, Zebro T. Prostaglandins from tumours of human large bowel. Br J Cancer. 1977;35:881-884. [PMID: 871372 DOI: 10.1038/bjc.1977.132] [Cited by in Crossref: 143] [Cited by in F6Publishing: 119] [Article Influence: 3.2] [Reference Citation Analysis]
Number Citing Articles
1 Yamaki T, Yano T, Satoh H, Endo T, Matsuyama C, Kumagai H, Miyahara M, Sakurai H, Pokorny J, Shin SJ, Hagiwara K. High oleic acid oil suppresses lung tumorigenesis in mice through the modulation of extracellular signal-regulated kinase cascade. Lipids 2002;37:783-8. [DOI: 10.1007/s11745-002-0961-8] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.5] [Reference Citation Analysis]
2 Hsi LC, Joon Baek S, Eling TE. Lack of Cyclooxygenase-2 Activity in HT-29 Human Colorectal Carcinoma Cells. Experimental Cell Research 2000;256:563-70. [DOI: 10.1006/excr.2000.4863] [Cited by in Crossref: 45] [Cited by in F6Publishing: 43] [Article Influence: 2.0] [Reference Citation Analysis]
3 Taketo MM. Cyclooxygenase-2 inhibitors in tumorigenesis (Part II). J Natl Cancer Inst. 1998;90:1609-1620. [PMID: 9811310 DOI: 10.1093/jnci/90.21.1609] [Cited by in Crossref: 345] [Cited by in F6Publishing: 299] [Article Influence: 14.4] [Reference Citation Analysis]
4 Bartram H, Gostner A, Scheppach W, Reddy BS, Rao CV, Dusel G, Richter F, Richter A, Kasper H. Effects of fish oil on rectal cell proliferation, mucosal fatty acids, and prostaglandin E2 release in healthy subjects. Gastroenterology 1993;105:1317-22. [DOI: 10.1016/0016-5085(93)90135-y] [Cited by in Crossref: 111] [Cited by in F6Publishing: 36] [Article Influence: 3.8] [Reference Citation Analysis]
5 Johnson JT, Rabin BS, Wagner RL. Prostaglandin E 2 of the Upper Aerodigestive Tract. Ann Otol Rhinol Laryngol 1987;96:213-6. [DOI: 10.1177/000348948709600215] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 2.7] [Reference Citation Analysis]
6 Liu CY, Lai YY, Lo CJ. Levamisole modulates prostaglandin E2 production and cyclooxygenase II gene expression in human colonic cancer cells. J Surg Res. 2004;117:223-231. [PMID: 15047127 DOI: 10.1016/j.jss.2003.11.010] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.4] [Reference Citation Analysis]
7 Pugh S, Thomas GA. Patients with adenomatous polyps and carcinomas have increased colonic mucosal prostaglandin E2. Gut. 1994;35:675-678. [PMID: 8200564 DOI: 10.1136/gut.35.5.675] [Cited by in Crossref: 182] [Cited by in F6Publishing: 169] [Article Influence: 6.5] [Reference Citation Analysis]
8 Chaimoff C, Malachi T, Halbrecht I. Prostaglandin E2 and cyclic nucleotides in plasma and urine of colonic cancer patients. J Cancer Res Clin Oncol 1985;110:153-6. [DOI: 10.1007/bf00402730] [Cited by in Crossref: 11] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
9 Metz SA, Mcrae JR, Robertson R. Prostaglandins as mediators of paraneoplastic syndromes: Review and up-date. Metabolism 1981;30:299-316. [DOI: 10.1016/0026-0495(81)90156-6] [Cited by in Crossref: 39] [Cited by in F6Publishing: 29] [Article Influence: 1.0] [Reference Citation Analysis]
10 Xu XC. COX-2 inhibitors in cancer treatment and prevention, a recent development. Anticancer Drugs. 2002;13:127-137. [PMID: 11901304 DOI: 10.1097/00001813-200202000-00003] [Cited by in Crossref: 125] [Cited by in F6Publishing: 120] [Article Influence: 6.3] [Reference Citation Analysis]
11 Yang C, Takezaki T, Hirose K, Inoue M, Huang X, Tajima K. Fish consumption and colorectal cancer: a case–reference study in Japan: . European Journal of Cancer Prevention 2003;12:109-15. [DOI: 10.1097/00008469-200304000-00004] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 1.5] [Reference Citation Analysis]
12 Paganini-Hill A. Aspirin and the prevention of colorectal cancer: a review of the evidence. Semin Surg Oncol 1994;10:158-64. [PMID: 8085092 DOI: 10.1002/ssu.2980100303] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 0.6] [Reference Citation Analysis]
13 Brown JR, DuBois RN. COX-2: a molecular target for colorectal cancer prevention. J Clin Oncol. 2005;23:2840-2855. [PMID: 15837998 DOI: 10.1200/jco.2005.09.051] [Cited by in Crossref: 368] [Cited by in F6Publishing: 182] [Article Influence: 21.6] [Reference Citation Analysis]
14 Stoeltzing O, Liu W, Fan F, Wagner C, Stengel K, Somcio RJ, Reinmuth N, Parikh AA, Hicklin DJ, Ellis LM. Regulation of cyclooxygenase-2 (COX-2) expression in human pancreatic carcinoma cells by the insulin-like growth factor-I receptor (IGF-IR) system. Cancer Lett. 2007;258:291-300. [PMID: 17950526 DOI: 10.1016/j.canlet.2007.09.009] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 1.4] [Reference Citation Analysis]
15 Kawamoto T, Shoda J, Asano T, Ueda T, Furukawa M, Koike N, Tanaka N, Todoroki T, Miwa M. Expression of cyclooxygenase-2 in the subserosal layer correlates with postsurgical prognosis of pathological tumor stage 2 carcinoma of the gallbladder. Int J Cancer. 2002;98:427-434. [PMID: 11920595 DOI: 10.1002/ijc.10222] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 1.0] [Reference Citation Analysis]
16 Baker PE, Fahey JV, Munck A. Prostaglandin inhibition of T-cell proliferation is mediated at two levels. Cellular Immunology 1981;61:52-61. [DOI: 10.1016/0008-8749(81)90353-1] [Cited by in Crossref: 154] [Cited by in F6Publishing: 144] [Article Influence: 3.8] [Reference Citation Analysis]
17 Manigandan K, Manimaran D, Jayaraj RL, Elangovan N, Dhivya V, Kaphle A. Taxifolin curbs NF-κB-mediated Wnt/β-catenin signaling via up-regulating Nrf2 pathway in experimental colon carcinogenesis. Biochimie 2015;119:103-12. [PMID: 26482805 DOI: 10.1016/j.biochi.2015.10.014] [Cited by in Crossref: 51] [Cited by in F6Publishing: 48] [Article Influence: 7.3] [Reference Citation Analysis]
18 Earnet DL, Hixson LJ, Alberts DS. Piroxicam and other cyclooxygenase inhibitors: Potential for cancer chemoprevention. J Cell Biochem 1992;50:156-66. [DOI: 10.1002/jcb.240501330] [Cited by in Crossref: 73] [Cited by in F6Publishing: 71] [Article Influence: 2.4] [Reference Citation Analysis]
19 Honn KV, Bockman RS, Marnett LJ. Prostaglandins and cancer: a review of tumor initiation through tumor metastasis. Prostaglandins 1981;21:833-64. [PMID: 6280245 DOI: 10.1016/0090-6980(81)90240-9] [Cited by in Crossref: 199] [Cited by in F6Publishing: 179] [Article Influence: 5.0] [Reference Citation Analysis]
20 Parker J, Kaplon MK, Alvarez CJ, Krishnaswamy G. Prostaglandin H synthase expression is variable in human colorectal adenocarcinoma cell lines. Exp Cell Res. 1997;236:321-329. [PMID: 9344613 DOI: 10.1006/excr.1997.3741] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 1.1] [Reference Citation Analysis]
21 Bennett A, Civier A, Hensby CN, Melhuish PB, Stamford IF. Measurement of arachidonate and its metabolites extracted from human normal and malignant gastrointestinal tissues. Gut 1987;28:315-8. [PMID: 3106172 DOI: 10.1136/gut.28.3.315] [Cited by in Crossref: 74] [Cited by in F6Publishing: 69] [Article Influence: 2.1] [Reference Citation Analysis]
22 Petry FM, Tutton PJ, Barkla DH. The influence of arachidonic acid metabolites on cell division in the intestinal epithelium and in colonic tumors. Prostaglandins, Leukotrienes and Medicine 1984;15:349-58. [DOI: 10.1016/0262-1746(84)90134-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.1] [Reference Citation Analysis]
23 Mujagić H, Krnjajić N, Jevrić A. The levels and relations of prostaglandins in pregnant and non-pregnant tumor-bearing mice. J Cancer Res Clin Oncol 1989;115:383-7. [PMID: 2760103 DOI: 10.1007/BF00400967] [Reference Citation Analysis]
24 Rampton DS, Hawkey CJ. Prostaglandins and ulcerative colitis. Gut. 1984;25:1399-1413. [PMID: 6150882 DOI: 10.1136/gut.25.12.1399] [Cited by in Crossref: 99] [Cited by in F6Publishing: 93] [Article Influence: 2.7] [Reference Citation Analysis]
25 Neoptolemos JP, Husband D, Imray C, Rowley S, Lawson N. Arachidonic acid and docosahexaenoic acid are increased in human colorectal cancer. Gut 1991;32:278-81. [PMID: 1826490 DOI: 10.1136/gut.32.3.278] [Cited by in Crossref: 40] [Cited by in F6Publishing: 41] [Article Influence: 1.3] [Reference Citation Analysis]
26 Kraft TE, Parisotto D, Schempp C, Efferth T. Fighting Cancer with Red Wine? Molecular Mechanisms of Resveratrol. Critical Reviews in Food Science and Nutrition 2009;49:782-99. [DOI: 10.1080/10408390802248627] [Cited by in Crossref: 66] [Cited by in F6Publishing: 61] [Article Influence: 5.1] [Reference Citation Analysis]
27 Leaper DJ, French BT, Bennett A. Breast cancer and prostaglandins: a new approach to treatment. Br J Surg 1979;66:683-6. [PMID: 509040 DOI: 10.1002/bjs.1800661004] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 0.4] [Reference Citation Analysis]
28 Xie W, Robertson DL, Simmons DL. Mitogen-inducible prostaglandin G/H synthase: A new target for nonsteroidal antiinflammatory drugs. Drug Dev Res 1992;25:249-65. [DOI: 10.1002/ddr.430250402] [Cited by in Crossref: 235] [Cited by in F6Publishing: 192] [Article Influence: 7.8] [Reference Citation Analysis]
29 Rigas B, Shiff S. Is inhibition of cyclooxygenase required for the chemopreventive effect of NSAIDs in colon cancer? A model reconciling the current contradiction. Medical Hypotheses 2000;54:210-5. [DOI: 10.1054/mehy.1999.0023] [Cited by in Crossref: 61] [Cited by in F6Publishing: 55] [Article Influence: 2.8] [Reference Citation Analysis]
30 Kalmar L, Gyires K, Gergely P. Inhibitory effect of tumour cells on leukocyte motility. Immunology Letters 1984;8:175-7. [DOI: 10.1016/0165-2478(84)90073-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
31 Amissah F, Duverna R, Aguilar BJ, Poku RA, Lamango NS. Polyisoprenylated methylated protein methyl esterase is both sensitive to curcumin and overexpressed in colorectal cancer: implications for chemoprevention and treatment. Biomed Res Int 2013;2013:416534. [PMID: 23936796 DOI: 10.1155/2013/416534] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
32 Sato M, Narisawa T, Sano M, Takahashi T, Goto A. Growth inhibition of transplantable murine colon adenocarcinoma 38 by indomethacin. J Cancer Res Clin Oncol 1983;106:21-6. [PMID: 6885896 DOI: 10.1007/BF00399893] [Cited by in Crossref: 22] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
33 Simmons DL, Botting RM, Hla T. Cyclooxygenase Isozymes: The Biology of Prostaglandin Synthesis and Inhibition. Pharmacol Rev 2004;56:387-437. [DOI: 10.1124/pr.56.3.3] [Cited by in Crossref: 1095] [Cited by in F6Publishing: 978] [Article Influence: 60.8] [Reference Citation Analysis]
34 Kashfi K, Rigas B. Non-COX-2 targets and cancer: Expanding the molecular target repertoire of chemoprevention. Biochemical Pharmacology 2005;70:969-86. [DOI: 10.1016/j.bcp.2005.05.004] [Cited by in Crossref: 72] [Cited by in F6Publishing: 69] [Article Influence: 4.2] [Reference Citation Analysis]
35 Morgan GP, Williams JG. Aspirin and risk of fatal colon cancer. Postgrad Med J 1993;69:893-4. [PMID: 8290442 DOI: 10.1136/pgmj.69.817.893-a] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
36 Lala PK. PGE2 Mediated Inactivation of Potentially Tumoricidal Effector Cells of the Host during Tumor Development: Relevance to Metastasis and Immunotherapy. In: Abraham S, editor. Carcinogenesis and Dietary Fat. Boston: Springer US; 1989. pp. 219-32. [DOI: 10.1007/978-1-4613-1585-8_13] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
37 Yamaguchi A, Ishida T, Nishimura G, Katoh M, Miyazaki I. Investigation of colonic prostaglandins in carcinogenesis in the rat colon. Dis Colon Rectum 1991;34:572-6. [PMID: 2055143 DOI: 10.1007/BF02049897] [Cited by in Crossref: 18] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
38 Talcott PA, Exon JH, Mather GG, Koller LD. Alterations of rat natural killer (NK) cell cytotoxicity and cytokine production by 3-methylcholanthrene (3-MC). Int J Immunopharmacol 1990;12:917-26. [PMID: 2292469 DOI: 10.1016/0192-0561(90)90012-c] [Cited by in Crossref: 6] [Article Influence: 0.2] [Reference Citation Analysis]
39 Vane J, Botting R. Biological Properties of Cyclooxygenase Products. Lipid Mediators. Elsevier; 1994. pp. 61-97. [DOI: 10.1016/b978-0-12-198875-3.50009-8] [Cited by in Crossref: 5] [Article Influence: 0.2] [Reference Citation Analysis]
40 Tow BP, Tan MH. Delayed diagnosis of Ewing's sarcoma of the right humerus initially treated as chronic osteomyelitis: a case report. J Orthop Surg (Hong Kong) 2005;13:88-92. [PMID: 15872409 DOI: 10.1177/230949900501300117] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
41 Narisawa T, Kusaka H, Yamazaki Y, Takahashi M, Koyama H, Koyama K, Fukaura Y, Wakizaka A. Relationship between blood plasma prostaglandin E2 and liver and lung metastases in colorectal cancer. Dis Colon Rectum 1990;33:840-5. [PMID: 2209273 DOI: 10.1007/BF02051919] [Cited by in Crossref: 46] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
42 Levine L. Arachidonic Acid Transformation and Tumor Production. Elsevier; 1981. pp. 49-79. [DOI: 10.1016/s0065-230x(08)60908-2] [Cited by in Crossref: 92] [Cited by in F6Publishing: 9] [Article Influence: 2.2] [Reference Citation Analysis]
43 Goodwin JS, Ceuppens J. Regulation of the immune response by prostaglandins. J Clin Immunol 1983;3:295-315. [DOI: 10.1007/bf00915791] [Cited by in Crossref: 509] [Cited by in F6Publishing: 95] [Article Influence: 13.1] [Reference Citation Analysis]
44 Ramalingam S, Belani CP. Cyclooxygenase-2 Inhibitors in Lung Cancer. Clinical Lung Cancer 2004;5:245-53. [DOI: 10.3816/clc.2004.n.006] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
45 Schnitzler M, Dwight T, Robinson BG. Sulindac increases the expression of APC mRNA in malignant colonic epithelial cells: an in vitro study. Gut 1996;38:707-13. [PMID: 8707116 DOI: 10.1136/gut.38.5.707] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 0.5] [Reference Citation Analysis]
46 Awad AB, Kamei A, Horvath PJ, Fink CS. Prostaglandin synthesis in human cancer cells: influence of fatty acids and butyrate. Prostaglandins Leukot Essent Fatty Acids 1995;53:87-93. [PMID: 7480078 DOI: 10.1016/0952-3278(95)90134-5] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 0.6] [Reference Citation Analysis]
47 Hsi LC, Angerman-stewart J, Eling TE. Introduction of full-length APC modulates cyclooxygenase-2 expression in HT-29 human colorectal carcinoma cells at the translational level. Carcinogenesis 1999;20:2045-9. [DOI: 10.1093/carcin/20.11.2045] [Cited by in Crossref: 39] [Cited by in F6Publishing: 38] [Article Influence: 1.7] [Reference Citation Analysis]
48 Boyd EJ, Hulks G, Thomas JS, McColl KE. Hypertrophic gastritis associated with increased gastric mucosal prostaglandin E2 concentrations in a patient with the carcinoid syndrome. Gut 1988;29:1270-6. [PMID: 3198004 DOI: 10.1136/gut.29.9.1270] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
49 Bennett A. Prostaglandins and Cancer. In: Karim SMM, editor. Practical Applications of Prostaglandins and their Synthesis Inhibitors. Dordrecht: Springer Netherlands; 1979. pp. 149-88. [DOI: 10.1007/978-94-011-7843-3_9] [Cited by in Crossref: 22] [Cited by in F6Publishing: 14] [Article Influence: 0.5] [Reference Citation Analysis]
50 Anti M, Marra G, Armelao F, Bartoli GM, Ficarelli R, Percesepe A, De Vitis I, Maria G, Sofo L, Rapaccini GL, Gentiloni N, Piccioni E, Miggiano G. Effect of ω-3 fatty acids on rectal mucosal cell proliferation in subjects at risk for colon cancer. Gastroenterology 1992;103:883-91. [DOI: 10.1016/0016-5085(92)90021-p] [Cited by in Crossref: 151] [Cited by in F6Publishing: 45] [Article Influence: 5.0] [Reference Citation Analysis]
51 Goodwin JS, Husby G, Williams RC. Prostaglandin E and cancer Growth. Cancer Immunol Immunother 1980;8:3-7. [DOI: 10.1007/bf00206347] [Cited by in Crossref: 49] [Article Influence: 1.2] [Reference Citation Analysis]
52 Hawkey CJ, Rampton DS. Prostaglandins and the gastrointestinal mucosa: are they important in its function, disease, or treatment? Gastroenterology 1985;89:1162-88. [PMID: 3930341 DOI: 10.1016/0016-5085(85)90225-2] [Cited by in Crossref: 288] [Cited by in F6Publishing: 260] [Article Influence: 7.8] [Reference Citation Analysis]
53 Sulciner ML, Gartung A, Gilligan MM, Serhan CN, Panigrahy D. Targeting lipid mediators in cancer biology. Cancer Metastasis Rev 2018;37:557-72. [PMID: 30136088 DOI: 10.1007/s10555-018-9754-9] [Cited by in Crossref: 23] [Cited by in F6Publishing: 26] [Article Influence: 7.7] [Reference Citation Analysis]
54 Bertagnolli MM. The potential of non-steroidal anti-inflammatory drugs (NSAIDs) for colorectal cancer prevention. J Surg Oncol. 2003;84:113-119. [PMID: 14598353 DOI: 10.1002/jso.10279] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
55 Kurata Y, Asamoto M, Hagiwara A, Masui T, Fukushima S. Promoting effects of various agents in rat urinary bladder carcinogenesis initiated by N-butyl-N-(4-hydroxybutyl)nitrosamine. Cancer Letters 1986;32:125-35. [DOI: 10.1016/0304-3835(86)90110-2] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 0.6] [Reference Citation Analysis]
56 Karmali RA. Review: Prostaglandins and cancer. Prostaglandins and Medicine 1980;5:11-28. [DOI: 10.1016/0161-4630(80)90086-5] [Cited by in Crossref: 87] [Cited by in F6Publishing: 78] [Article Influence: 2.1] [Reference Citation Analysis]
57 Sharma RA, Manson MM, Gescher A, Steward WP. Colorectal cancer chemoprevention: biochemical targets and clinical development of promising agents. Eur J Cancer. 2001;37:12-22. [PMID: 11165125 DOI: 10.1016/s0959-8049(00)00326-9] [Cited by in Crossref: 36] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]
58 Elattar TMA. Cancer and the prostaglandins: a mini review on cancer research. J Oral Pathol Med 1985;14:511-22. [DOI: 10.1111/j.1600-0714.1985.tb00524.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 0.4] [Reference Citation Analysis]
59 Bennett A, Stockley HL. The contribution of prostaglandins in the muscle of human isolated small intestine to neurogenic responses. Br J Pharmacol 1977;61:573-8. [PMID: 597664 DOI: 10.1111/j.1476-5381.1977.tb07550.x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 0.4] [Reference Citation Analysis]
60 Thun MJ. Do NSAIDs prevent colorectal cancer? Drug Discovery Today 1996;1:495-6. [DOI: 10.1016/s1359-6446(96)20010-8] [Cited by in Crossref: 1] [Article Influence: 0.0] [Reference Citation Analysis]
61 O’Keefe SJ. Nutrition and gastrointestinal disease. Scand J Gastroenterol Suppl. 1996;220:52-59. [PMID: 8898436 DOI: 10.3109/00365529609094750] [Cited by in Crossref: 25] [Cited by in F6Publishing: 16] [Article Influence: 1.0] [Reference Citation Analysis]
62 Birkenfeld S, Zaltsman YA, Krispin M, Zakut H, Zor U, Kohen F. Antitumor effects of inhibitors of arachidonic acid cascade on experimentally induced intestinal tumors. Dis Colon Rectum 1987;30:43-6. [PMID: 3803107 DOI: 10.1007/BF02556922] [Cited by in Crossref: 16] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
63 Soydan AS, Gaffen JD, Weech PK, Tremblay NM, Kargman S, O'Neill G, Bennett A, Tavares IA. Cytosolic phospholipase A2, cyclo-oxygenases and arachidonate in human stomach tumours. Eur J Cancer. 1997;33:1508-1512. [PMID: 9337697 DOI: 10.1016/s0959-8049(97)00168-8] [Cited by in Crossref: 28] [Cited by in F6Publishing: 5] [Article Influence: 1.1] [Reference Citation Analysis]
64 Winde G, Gumbinger HG, Osswald H, Kemper F, Bünte H. The NSAID sulindac reverses rectal adenomas in colectomized patients with familial adenomatous polyposis: clinical results of a dose-finding study on rectal sulindac administration. Int J Colorectal Dis 1993;8:13-7. [PMID: 8388011 DOI: 10.1007/BF00341270] [Cited by in Crossref: 59] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
65 Souza Filho JP, Martins MC, Correa ZMS, Odashiro AN, Antecka E, Coutinho AB, Macedo CR, Vianna RN, Burnier MN. The Expression of Cyclooxygenase 2 in Retinoblastoma: Primary Enucleated Eyes and Enucleation After Conservative Treatment. American Journal of Ophthalmology 2006;142:625-631.e1. [DOI: 10.1016/j.ajo.2006.05.053] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.7] [Reference Citation Analysis]
66 Goodwin JS. Prostaglandin Synthetase Inhibitors as Immunoadjuvants in the Treatment of Cancer. Journal of Immunopharmacology 2008;2:397-424. [DOI: 10.3109/08923978009026403] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 1.4] [Reference Citation Analysis]
67 Kim TH, Jeong YI, Jin SG, Pei J, Jung TY, Moon KS, Kim IY, Kang SS, Jung S. Preparation of polylactide-co-glycolide nanoparticles incorporating celecoxib and their antitumor activity against brain tumor cells. Int J Nanomedicine 2011;6:2621-31. [PMID: 22114493 DOI: 10.2147/IJN.S19497] [Cited by in Crossref: 20] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
68 Thun MJ. Aspirin, NSAIDs, and digestive tract cancers. Cancer Metast Rev 1994;13:269-77. [DOI: 10.1007/bf00666097] [Cited by in Crossref: 43] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
69 Ulrich CM, Bigler J, Potter JD. Non-steroidal anti-inflammatory drugs for cancer prevention: promise, perils and pharmacogenetics. Nat Rev Cancer. 2006;6:130-140. [PMID: 16491072 DOI: 10.1038/nrc1801] [Cited by in Crossref: 399] [Cited by in F6Publishing: 371] [Article Influence: 24.9] [Reference Citation Analysis]
70 Slattery ML. Physical activity and colorectal cancer. Sports Med 2004;34:239-52. [PMID: 15049716 DOI: 10.2165/00007256-200434040-00004] [Cited by in Crossref: 115] [Cited by in F6Publishing: 92] [Article Influence: 6.4] [Reference Citation Analysis]
71 Thun MJ. NSAID use and decreased risk of gastrointestinal cancers. Gastroenterol Clin North Am. 1996;25:333-348. [PMID: 9229576 DOI: 10.1016/s0889-8553(05)70250-8] [Cited by in Crossref: 83] [Cited by in F6Publishing: 20] [Article Influence: 3.3] [Reference Citation Analysis]
72 Bennett A, Sanger GJ. Acidic Lipids: Prostaglandins. In: Bertaccini G, editor. Mediators and Drugs in Gastrointestinal Motility II. Berlin: Springer Berlin Heidelberg; 1982. pp. 219-48. [DOI: 10.1007/978-3-642-68474-6_8] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
73 Lynch NR, Castes M, Astoin M, Salomon JC. Mechanism of inhibition of tumour growth by aspirin and indomethacin. Br J Cancer 1978;38:503-12. [PMID: 365211 DOI: 10.1038/bjc.1978.237] [Cited by in Crossref: 118] [Cited by in F6Publishing: 114] [Article Influence: 2.7] [Reference Citation Analysis]
74 Nicholson ML, Neoptolemos JP, Clayton HA, Talbot IC, Bell PR. Increased cell membrane arachidonic acid in experimental colorectal tumours. Gut 1991;32:413-8. [PMID: 2026340 DOI: 10.1136/gut.32.4.413] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 0.7] [Reference Citation Analysis]
75 Martínez ME, Heddens D, Earnest DL, Bogert CL, Roe D, Einspahr J, Marshall JR, Alberts DS. Physical activity, body mass index, and prostaglandin E2 levels in rectal mucosa. J Natl Cancer Inst 1999;91:950-3. [PMID: 10359547 DOI: 10.1093/jnci/91.11.950] [Cited by in Crossref: 74] [Cited by in F6Publishing: 62] [Article Influence: 3.2] [Reference Citation Analysis]
76 Rao CV, Patlolla JM, Cooma I, Kawamori T, Steele VE. Prevention of Familial Adenomatous Polyp Development in APC min Mice and Azoxymethane-Induced Colon Carcinogenesis in F344 Rats by ω-3 Fatty Acid Rich Perilla Oil. Nutrition and Cancer 2013;65:54-60. [DOI: 10.1080/01635581.2013.785009] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
77 Kubota Y, Sunouchi K, Ono M, Sawada T, Muto T. Local immunity and metastasis of colorectal carcinoma. Diseases of the Colon & Rectum 1992;35:645-50. [DOI: 10.1007/bf02053754] [Cited by in Crossref: 22] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
78 Harris RE, Beebe-Donk J, Alshafie GA. Reduced risk of human lung cancer by selective cyclooxygenase 2 (COX-2) blockade: results of a case control study. Int J Biol Sci 2007;3:328-34. [PMID: 17589567 DOI: 10.7150/ijbs.3.328] [Cited by in Crossref: 58] [Cited by in F6Publishing: 55] [Article Influence: 3.9] [Reference Citation Analysis]
79 Mukhtar H. Chemoprevention: Making it a success story for controlling human cancer. Cancer Letters 2012;326:123-7. [DOI: 10.1016/j.canlet.2012.05.016] [Cited by in Crossref: 27] [Cited by in F6Publishing: 21] [Article Influence: 2.7] [Reference Citation Analysis]
80 Bennett A, Carter RL, Stamford IF, Tanner NS. Prostaglandin-like material extracted from squamous carcinomas of the head and neck. Br J Cancer 1980;41:204-8. [PMID: 7370160 DOI: 10.1038/bjc.1980.31] [Cited by in Crossref: 53] [Cited by in F6Publishing: 54] [Article Influence: 1.3] [Reference Citation Analysis]
81 Botti C, Seregni E, Ferrari L, Martinetti A, Bombardieri E. Immunosuppressive Factors: Role in Cancer Development and Progression. Int J Biol Markers 1998;13:51-69. [DOI: 10.1177/172460089801300201] [Cited by in Crossref: 42] [Cited by in F6Publishing: 33] [Article Influence: 10.5] [Reference Citation Analysis]
82 Honn KV, Onoda JM, Menter DG, Taylor JD, Sloane BF. Prostacyclin/Thromboxanes and Tumor Cell Metastasis. In: Honn KV, Sloane BF, editors. Hemostatic Mechanisms and Metastasis. Boston: Springer US; 1984. pp. 207-31. [DOI: 10.1007/978-1-4613-3831-4_14] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
83 Dirsch VM, Vollmar AM. Ajoene, a natural product with non-steroidal anti-inflammatory drug (NSAID)-like properties? Biochem Pharmacol 2001;61:587-93. [PMID: 11239502 DOI: 10.1016/s0006-2952(00)00580-3] [Cited by in Crossref: 37] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
84 Wang Q, Fan LY, He J, Wang YH. Inhibitory effect of sulindac against chemically-induced primary colonic tumors by N-methyl-N-nitrosourea in mice. World J Gastroenterol 1997; 3(1): 16-18 [PMID: 27006576 DOI: 10.3748/wjg.v3.i1.16] [Reference Citation Analysis]
85 Okuno M, Tanaka T, Komaki C, Nagase S, Shiratori Y, Muto Y, Kajiwara K, Maki T, Moriwaki H. Suppressive effect of low amounts of safflower and perilla oils on diethylnitrosamine‐induced hepatocarcinogenesis in male F344 rats. Nutrition and Cancer 1998;30:186-93. [DOI: 10.1080/01635589809514662] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
86 Giardiello FM, Spannhake EW, DuBois RN, Hylind LM, Robinson CR, Hubbard WC, Hamilton SR, Yang VW. Prostaglandin levels in human colorectal mucosa: effects of sulindac in patients with familial adenomatous polyposis. Dig Dis Sci. 1998;43:311-316. [PMID: 9512123 DOI: 10.1023/A:1018898120673] [Cited by in Crossref: 62] [Cited by in F6Publishing: 18] [Article Influence: 2.6] [Reference Citation Analysis]
87 Church RD, Fleshman JW, McLeod HL. Cyclo-oxygenase 2 inhibition in colorectal cancer therapy. Br J Surg. 2003;90:1055-1067. [PMID: 12945071 DOI: 10.1002/bjs.4297] [Cited by in Crossref: 36] [Cited by in F6Publishing: 31] [Article Influence: 1.9] [Reference Citation Analysis]
88 Umeda-Sawada R, Fujiwara Y, Ushiyama I, Sagawa S, Morimitsu Y, Kawashima H, Ono Y, Kiso Y, Matsumoto A, Seyama Y. Distribution and metabolism of dihomo-gamma-linolenic acid (DGLA, 20:3n-6) by oral supplementation in rats. Biosci Biotechnol Biochem 2006;70:2121-30. [PMID: 16960355 DOI: 10.1271/bbb.60057] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 1.3] [Reference Citation Analysis]
89 Moorghen M, Ince P, Finney KJ, Sunter JP, Appleton DR, Watson AJ. A protective effect of sulindac against chemically-induced primary colonic tumours in mice. J Pathol 1988;156:341-7. [DOI: 10.1002/path.1711560411] [Cited by in Crossref: 89] [Cited by in F6Publishing: 82] [Article Influence: 2.6] [Reference Citation Analysis]
90 Jelińska M, Tokarz A, Olędzka R, Czorniuk-śliwa A. Effects of dietary linseed, evening primrose or fish oils on fatty acid and prostaglandin E2 contents in the rat livers and 7,12-dimethylbenz[a]anthracene-induced tumours. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2003;1637:193-9. [DOI: 10.1016/s0925-4439(03)00020-6] [Cited by in Crossref: 11] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
91 Ostrowski J, Wocial T, Skurzak H, Bartnik W. Do altering in ornithine decarboxylase activity and gene expression contribute to antiproliferative properties of COX inhibitors? Br J Cancer. 2003;88:1143-1151. [PMID: 12671717 DOI: 10.1038/sj.bjc.6600815] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 1.1] [Reference Citation Analysis]
92 Bertagnolli MM. Cox-2 and cancer chemoprevention: picking up the pieces. Recent Results Cancer Res 2007;174:73-8. [PMID: 17302187 DOI: 10.1007/978-3-540-37696-5_7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
93 Bartram HP, Krüger S, Dusel G, El-Bayoumy K, Upadhyaya P, Scheppach W. Antiproliferative effect of 1,4-phenylenebis(methylene)selenocyanate (p-XSC) on colonic epithelium of patients with adenomatous polyps in vitro. Eur J Cancer Prev 2003;12:463-8. [PMID: 14639123 DOI: 10.1097/00008469-200312000-00004] [Reference Citation Analysis]
94 Harris RE, Beebe-donk J, Alshafie GA. Cancer Chemoprevention by Cyclooxygenase 2 (COX-2) Blockade. In: Harris RE, Bittman R, Dasgupta D, Engelhardt H, Flohe L, Herrmann H, Holzenburg A, Nasheuer H, Rottem S, Wyss M, Zwickl P, editors. Inflammation in the Pathogenesis of Chronic Diseases. Dordrecht: Springer Netherlands; 2007. pp. 193-212. [DOI: 10.1007/1-4020-5688-5_9] [Cited by in Crossref: 69] [Cited by in F6Publishing: 54] [Article Influence: 4.6] [Reference Citation Analysis]
95 Plastaras JP, Guengerich FP, Nebert DW, Marnett LJ. Xenobiotic-metabolizing cytochromes P450 convert prostaglandin endoperoxide to hydroxyheptadecatrienoic acid and the mutagen, malondialdehyde. J Biol Chem. 2000;275:11784-11790. [PMID: 10766802 DOI: 10.1074/jbc.275.16.11784] [Cited by in Crossref: 54] [Cited by in F6Publishing: 51] [Article Influence: 2.5] [Reference Citation Analysis]
96 Hecht JR. Dietary fat and colon cancer. Adv Exp Med Biol 1996;399:157-63. [PMID: 8937555 DOI: 10.1007/978-1-4613-1151-5_12] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
97 Li S, Zhao X, Wu Z, Li Y, Zhu L, Cui B, Dong X, Tian S, Hu F, Zhao Y. Polymorphisms in arachidonic acid metabolism-related genes and the risk and prognosis of colorectal cancer. Fam Cancer. 2013;12:755-765. [PMID: 23715757 DOI: 10.1007/s10689-013-9659-2] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.5] [Reference Citation Analysis]
98 Hirata K, Itoh H, Ohsato K. Regression of rectal polyps by indomethacin suppository in familial adenomatous polyposis. Report of two cases. Dis Colon Rectum 1994;37:943-6. [PMID: 8076496 DOI: 10.1007/BF02052603] [Cited by in Crossref: 16] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
99 Lawson JA, Adams WJ, Morris DL. THE EFFECT OF MISOPROSTOL ON COLON CANCER. ANZ J Surg 1994;64:197-201. [DOI: 10.1111/j.1445-2197.1994.tb02178.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
100 Rogan-grgas J, Milas L, Hauptmann E, Nola P, Kolarić K, Maričić Z, Malenica B. Influence of Splenectomy upon Immunologic Reactivity of Patients with Hodgkin'S Disease. Tumori 1981;67:539-47. [DOI: 10.1177/030089168106700605] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
101 Kroenke CH, Bennett GG, Fuchs C, Giovannucci E, Kawachi I, Schernhammer E, Holmes MD, Kubzansky LD. Depressive Symptoms and Prospective Incidence of Colorectal Cancer in Women. American Journal of Epidemiology 2005;162:839-48. [DOI: 10.1093/aje/kwi302] [Cited by in Crossref: 45] [Cited by in F6Publishing: 40] [Article Influence: 2.6] [Reference Citation Analysis]
102 Oliveria S, Christos P. The Epidemiology of Physical Activity and Cancer. Ann NY Acad Sci 1997;833:79-90. [DOI: 10.1111/j.1749-6632.1997.tb48595.x] [Cited by in Crossref: 43] [Cited by in F6Publishing: 40] [Article Influence: 1.7] [Reference Citation Analysis]
103 Latham P, Lund EK, Johnson IT. Dietary n-3 PUFA increases the apoptotic response to 1,2-dimethylhydrazine, reduces mitosis and suppresses the induction of carcinogenesis in the rat colon. Carcinogenesis 1999;20:645-50. [DOI: 10.1093/carcin/20.4.645] [Cited by in Crossref: 101] [Cited by in F6Publishing: 83] [Article Influence: 4.4] [Reference Citation Analysis]
104 Harris RE. Ibuprofen in the Prevention and Therapy of Cancer. In: Rainsford K, editor. Ibuprofen. Chichester: John Wiley & Sons, Ltd; 2015. pp. 518-46. [DOI: 10.1002/9781118743614.ch13] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
105 Bennett A, Stamford IF, Stockley HL. Estimation and characterization of prostaglandins in the human gastrointestinal tract. Br J Pharmacol 1977;61:579-86. [PMID: 597665 DOI: 10.1111/j.1476-5381.1977.tb07551.x] [Cited by in Crossref: 74] [Cited by in F6Publishing: 67] [Article Influence: 1.7] [Reference Citation Analysis]
106 Wolin KY, Tuchman H. Physical activity and gastrointestinal cancer prevention. Recent Results Cancer Res. 2011;186:73-100. [PMID: 21113761 DOI: 10.1007/978-3-642-04231-7_4] [Cited by in Crossref: 33] [Cited by in F6Publishing: 21] [Article Influence: 3.0] [Reference Citation Analysis]
107 Ray PK. Immunosuppressor control as a modality of cancer treatment: effect of plasma adsorption with Staphylococcus aureus protein A. Contemp Top Immunobiol 1985;15:147-211. [PMID: 3161699 DOI: 10.1007/978-1-4684-4931-0_5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
108 Nicolson GL. Cancer metastasis. Organ colonization and the cell-surface properties of malignant cells. Biochim Biophys Acta 1982;695:113-76. [PMID: 6763877 DOI: 10.1016/0304-419x(82)90020-8] [Cited by in Crossref: 17] [Cited by in F6Publishing: 99] [Article Influence: 0.4] [Reference Citation Analysis]
109 Nugent KP, Spigelman AD, Phillips RK. Tissue prostaglandin levels in familial adenomatous polyposis patients treated with sulindac. Dis Colon Rectum 1996;39:659-62. [PMID: 8646953 DOI: 10.1007/BF02056946] [Cited by in Crossref: 27] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
110 Okada F, Hosokawa M, Hasegawa J, Ishikawa M, Chiba I, Nakamura Y, Kobayashi H. Regression mechanisms of mouse fibrosarcoma cells after in vitro exposure to quercetin: Diminution of tumorigenicity with a corresponding decrease in the production of prostaglandin E2. Cancer Immunol Immunother 1990;31:358-64. [DOI: 10.1007/bf01741407] [Cited by in Crossref: 26] [Cited by in F6Publishing: 15] [Article Influence: 0.8] [Reference Citation Analysis]
111 Jiang JG, Tang JB, Chen CL, Liu BX, Fu XN, Zhu ZH, Qu W, Cianflone K, Waalkes MP, Wang DW. Expression of cyclooxygenase-2 in human esophageal squamous cell carcinomas. World J Gastroenterol 2004; 10(15): 2168-2173 [PMID: 15259059 DOI: 10.3748/wjg.v10.i15.2168] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.4] [Reference Citation Analysis]
112 Mehl LE. A mathematical computer stimulation model for the development of colonic polyps and colon cancer. J Surg Oncol 1991;47:243-52. [PMID: 1650408 DOI: 10.1002/jso.2930470409] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 0.4] [Reference Citation Analysis]
113 Goodwin JS, Ceuppens JL. Prostaglandins, Cellular Immunity and Cancer. In: Goodwin JS, editor. Prostaglandins and Immunity. Boston: Springer US; 1985. pp. 1-34. [DOI: 10.1007/978-1-4613-2603-8_1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.0] [Reference Citation Analysis]
114 Oka M, Inaba A, Uchiyama T, Hazama S, Shimoda K, Suzuki M, Suzuki T. Prostaglandin E2 levels and lymphocyte subsets in portal venous drainage of colorectal cancers. The American Journal of Surgery 1994;167:264-7. [DOI: 10.1016/0002-9610(94)90089-2] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 0.9] [Reference Citation Analysis]
115 Janssen A, Maier TJ, Schiffmann S, Coste O, Seegel M, Geisslinger G, Grösch S. Evidence of COX-2 independent induction of apoptosis and cell cycle block in human colon carcinoma cells after S- or R-ibuprofen treatment. Eur J Pharmacol. 2006;540:24-33. [PMID: 16730702 DOI: 10.1016/j.ejphar.2006.04.030] [Cited by in Crossref: 34] [Cited by in F6Publishing: 34] [Article Influence: 2.1] [Reference Citation Analysis]
116 Carter RL. Patterns and mechanisms of localized bone invasion by tumors: studies with squamous carcinomas of the head and neck. Crit Rev Clin Lab Sci 1985;22:275-315. [PMID: 3899510 DOI: 10.3109/10408368509165845] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 0.6] [Reference Citation Analysis]
117 Earnest DL, Alberts DS, Hixson LJ, Meyskens FL. Dietary Fiber or Piroxicam as Potential Cancer Prevention Agents: Effects on Rectal Epithelial Cell Proliferation in Humans at Increased Risk of Colon Cancer. In: Utsunomiya J, Lynch HT, editors. Hereditary Colorectal Cancer. Tokyo: Springer Japan; 1990. pp. 275-82. [DOI: 10.1007/978-4-431-68337-7_41] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.0] [Reference Citation Analysis]
118 Tsao SW, Burman JF, Pittam MR, Carter RL. Further observations on mechanisms of bone destruction by squamous carcinomas of the head and neck: the role of host stroma. Br J Cancer 1983;48:697-704. [PMID: 6580033 DOI: 10.1038/bjc.1983.252] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 0.3] [Reference Citation Analysis]
119 Wójcik M, Ramadori P, Blaschke M, Sultan S, Khan S, Malik IA, Naz N, Martius G, Ramadori G, Schultze FC. Immunodetection of cyclooxygenase-2 (COX-2) is restricted to tissue macrophages in normal rat liver and to recruited mononuclear phagocytes in liver injury and cholangiocarcinoma. Histochem Cell Biol. 2012;137:217-233. [PMID: 22131058 DOI: 10.1007/s00418-011-0889-9] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 2.3] [Reference Citation Analysis]
120 Plescia O, Pontieri G, Brown J, Racis S, Ippoliti F, Bellelli L, Sezzi M, Lipari M. Amplification by macrophages of prostaglandin-mediated immunosuppression in mice bearing syngeneic tumors. Prostaglandins, Leukotrienes and Medicine 1984;16:205-23. [DOI: 10.1016/0262-1746(84)90072-6] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.3] [Reference Citation Analysis]
121 Ross DS, Bitzer D, Roy T, Murphy JE. Piroxicam inhibits the growth of an adenocarcinoma isograft in Fischer rats. Journal of Surgical Research 1988;45:249-53. [DOI: 10.1016/0022-4804(88)90071-6] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 0.5] [Reference Citation Analysis]
122 Bertagnolli MM. Cyclooxygenase-2 and Chronic Inflammation: Drivers of Colorectal Tumorigenesis. In: Markowitz SD, Berger NA, editors. Energy Balance and Gastrointestinal Cancer. Boston: Springer US; 2012. pp. 157-82. [DOI: 10.1007/978-1-4614-2367-6_10] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]